Seeking Alpha

Nasdaq Biotechnology Index (NBI)

NBI is defunct.

NBI Related Articles more »

Insider Buys May Send The Wrong Signals

Edgar Ambartsoumian • Mon, Aug 22, 2011 • 4 Comments
Biotech’s Top and Bottom 10 From 2010

Michael Becker • Thu, Jan 6, 2011 • 2 Comments
Monoclonal Antibody Companies Command Premiums

Michael Becker • Mon, Jul 12, 2010 • 2 Comments
U.S. Rigs Show Steady Increase, But Woes Still Haunt Sector

Zacks Investment Research • Tue, Dec 1, 2009 • Comment!
Three Recent Biotech Activist Wins by Carl Icahn

Michael Becker • Mon, Aug 31, 2009 • 4 Comments
Pequot Capital: Yet Another Hedge Fund Buying Gold

Market Folly • Fri, Mar 27, 2009 • 2 Comments
Chink in the Biotechnology Armor

Michael Becker • Sun, Mar 1, 2009 • 4 Comments
The Bi-Polar Biotech Market Will Continue

Michael Shulman • Tue, Jul 8, 2008 • Comment!
Genentech 4th Quarter Report Leads Biotech Rally

H.S. Ayoub • Sat, Jan 13, 2007 • Comment!
Large Cap Biotech: The New Large Cap Pharma? (BTK, NBI, DRG)

Fri, Dec 9, 2005 • Comment!

NBI Latest Transcript more »

Currently, there are no transcripts for NBI.

NBI Cramer more »

Currently, there are no Cramer articles on NBI.

NBI Instablog posts more »

Credit Analysis: Nasdaq 100 Holdings

Fri, Oct 1, 2010 • Credit Lime • Comment!
Decoupled moves in Biotech indices highlight opportunities and challenges

Sat, Jul 25, 2009 • A. Reza Saadat • Comment!

Company Description

Currently, there's no company description for NBI.

Country: United States